Fred Jacobson

Statistics

Publications

Citations

884

H-Index

Active since

2009

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Fred Jacobson is an author at Memorial Sloan Kettering Cancer Center specializing in antibody-drug conjugates, pharmacy, and antibody characterization.

Publications per year

2009–2019

Publications

Phase I Study of Trastuzumab-DM1, an HER2 Antibody-Drug Conjugate, Given Every 3 Weeks to Patients With HER2-Positive Metastatic Breast Cancer

Ian E. Krop, Muralidhar Beeram, Shanu Modi et al. · Journal of Clinical Oncology · 2010 · 596 citations

Medicine, Oncology, Pharmacology +17

Statistical Modeling of the Drug Load Distribution on Trastuzumab Emtansine (Kadcyla), a Lysine-Linked Antibody Drug Conjugate

Michael T. Kim, Yan Chen, Joseph C. Marhoul et al. · Bioconjugate Chemistry · 2014 · 145 citations

Pharmacy, Pharmaceutics, Pharmacology +15

Streamlined Characterization of an Antibody–Drug Conjugate by Two-Dimensional and Four-Dimensional Liquid Chromatography/Mass Spectrometry

Alexandre Goyon, Michael T. Kim, Lu Dai et al. · Analytical Chemistry · 2019 · 52 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +17

Charge-based analysis of antibodies with engineered cysteines

Xiaoying Chen, Mary D.H. Nguyen, Fred Jacobson et al. · mAbs · 2009 · 40 citations · Full text

Pharmacy, Biochemistry, Molecular Biology +17

Structural Characterization of Cross-Linked Species in Trastuzumab Emtansine (Kadcyla)

Yan Chen, Michael T. Kim, Laura Zheng et al. · Bioconjugate Chemistry · 2016 · 35 citations

Pharmacy, Pharmaceutics, Pharmacology +17

1–5 of 6